RDNT RadNet Inc.

RadNet Announces the Agenda for its November 11, 2025 Investor Day

RadNet Announces the Agenda for its November 11, 2025 Investor Day

LOS ANGELES, Nov. 04, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services and a premier global developer of digital health solutions, is pleased to unveil the agenda for the company’s Investor Day.

The event will take place on Tuesday, November 11, 2025 from 9:00 a.m. to 2:30 p.m. Eastern Standard Time at the Nasdaq MarketSite in New York City. In-person attendance is by invitation only and investors can request such consideration by emailing . Those unable to participate onsite can view a live webcast at or see an archived replay of the event in the .

Titled “On the Leading Edge of Healthcare: Advancing Imaging Through Innovation and Technology,” the Investor Day will feature presentations from select RadNet senior executives and clinical leaders who will share the company’s current and longer-term strategic priorities, market opportunities and innovation roadmap.

The agenda is as follows:

  • 9:00 to 9:20 a.m. – Opening Remarks and Financial Overview
  • 9:20 to 11:00 a.m. – Expert Clinical Spotlights and Services Division Presentation
  • 11:00 to 11:30 a.m. – Q&A Session
  • 12:15 to 1:15 p.m. – Digital Health Division Presentation
  • 1:15 to 1:45 p.m. – Discussion About Unique Synergy of Services and Digital Health
  • 1:45 to 1:55 p.m. – Value-Creation Plan Towards 2028
  • 2:00 to 2:30 p.m. – Q&A Session

In-person attendees will have the exclusive opportunity to engage with RadNet’s leadership, talk with clinical and research experts and view the following demonstrations of RadNet’s DeepHealth cloud-native AI products:

  • Breast Suite – A portfolio of solutions designed to enhance quality, workflows and other aspects of diagnosing breast cancer.
  • Diagnostic Suite – Imaging platform that unites picture archiving and communications systems (PACS), multi-modality viewing, automated reporting, workflow tools and various AI-empowered clinical processes.
  • TechLive – Vendor-agnostic, remote scanning and radiology management solution designed to extend expert support for MR, ultrasound, CT and PET/CT across large, multi-site operations.
  • Patient Engagement – A portfolio of solutions aimed at improving patient scheduling, onboarding, follow-up interactions and online payments.

About RadNet, Inc.

RadNet, Inc. is a leading provider of outpatient diagnostic imaging services in the United States, with a network of 405 owned and/or operated imaging centers. The company’s markets include Arizona, California, Delaware, Florida, Maryland, New Jersey, New York and Texas. In addition, RadNet provides radiology information technology and artificial intelligence solutions marketed under the DeepHealth brand, teleradiology professional services and other related products and services to customers in the diagnostic imaging industry. Together with contracted radiologists, and inclusive of full-time and per diem employees and technologists, RadNet has over 11,000 team members. For more information, visit .

Contact:

RadNet, Inc.

Mark Stolper

Executive Vice President and Chief Financial Officer

310-445-2928

Or

Jane Mazur

Senior Vice President, Corporate Communications

Investor Relations:

Addo IR



EN
04/11/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on RadNet Inc.

Radnet Inc: 1 director

A director at Radnet Inc sold/sold after exercising options 45,088 shares at 78.332USD and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over t...

 PRESS RELEASE

DeepHealth Launches Breast Suite, Elevating Breast Cancer Detection, R...

DeepHealth Launches Breast Suite, Elevating Breast Cancer Detection, Risk Stratification and Workflow Breast Suite is an industry-leading, comprehensive, and modular AI-powered suite of applications supporting more than 10 million mammograms annually delivering increased breast cancer detection rates,1 risk stratification tools, and viewing and reporting workflow acceleration CHICAGO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- DeepHealth, a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), announced today the launch of the DeepHealth Brea...

 PRESS RELEASE

DeepHealth Unveils Next-Generation Imaging Informatics and Clinical AI...

DeepHealth Unveils Next-Generation Imaging Informatics and Clinical AI Solutions at RSNA 2025, Advancing a New Standard of AI-Powered Care Company expands portfolio of novel AI-powered clinical and operational solutions delivering proven impact at scale—empowering breakthroughs in care through imaging CHICAGO, Nov. 30, 2025 (GLOBE NEWSWIRE) -- DeepHealth, a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), today unveils an expanded portfolio at RSNA 2025, introducing next-generation imaging informatics and clinical AI solutions....

 PRESS RELEASE

RadNet’s DeepHealth Announces Wichita Radiological Group as First Oper...

RadNet’s DeepHealth Announces Wichita Radiological Group as First Operations Suite™ Customer Cloud-native platform selected to modernize operations, help improve efficiency and strengthen patient-centered care coordination across multi-site network SOMERVILLE, Mass., Nov. 20, 2025 (GLOBE NEWSWIRE) -- , a wholly owned subsidiary of (NASDAQ: RDNT) and a leader in AI-powered health informatics, today announced Wichita Radiological Group (WRG) has selected DeepHealth’s Operations Suite™1 to replace its legacy Radiology Information System (RIS) to advance operations, strengthen care coordi...

 PRESS RELEASE

Landmark Nature Health Study Demonstrates the Effectiveness of DeepHea...

Landmark Nature Health Study Demonstrates the Effectiveness of DeepHealth’s Novel AI-Powered Breast Cancer Detection Workflow Largest real-world analysis of AI-driven breast cancer screening in U.S. history1 demonstrates increased cancer detection rate with consistent benefits across patient populations LOS ANGELES and SOMERVILLE, Mass., Nov. 17, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), the nation's largest provider of outpatient diagnostic imaging services, and its wholly owned subsidiary, DeepHealth, a global leader in AI-powered health informatics, today announced results...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch